A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
Hanna Kahila, Terhi Saisto, Satu Kivitie-Kallio...
https://pubmed.ncbi.nlm.nih.gov/17364281/Actively Recruiting
Led by Holy Family Hospital, Nazareth, Israel · Updated on 2026-09-28
124
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are evaluating the use of Transcutaneous Electrical Nerve Stimulation TENS as a non-drug method to relieve postpartum uterine pain experienced during breastfeeding in women who have given birth multiple times. The study focuses on pain caused by natural oxytocin release that triggers strong uterine contractions shortly after delivery. Researchers aim to determine if TENS can reduce this pain and decrease the need for pain medications compared with standard care. Participants will be randomly assigned to one of two groups the TENS group or the standard care control group. The TENS group will have four electrodes placed on their lower abdomen and sacral area, delivering gentle electrical stimulation for 40 minutes during a breastfeeding session. The control group will receive usual postpartum pain management without TENS. Both groups will be monitored during two consecutive breastfeeding sessions within the first 48 hours after delivery. Participants will report pain levels using a 0 to 10 scale during breastfeeding sessions, and medication use will be recorded. Researchers will also track breastfeeding duration, any discomfort from TENS, adverse effects, and formula use. The study involves close monitoring within 48 hours postpartum and aims to assess whether TENS effectively reduces uterine pain and medication consumption during this early breastfeeding period.
CONDITIONS
TENS for Postpartum Uterine Pain During Breastfeeding
M
Marwa Bayatra, MD
R
RAED SALIM, PROF
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Holy Family Hospital, Nazareth, Israel
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 48 hours postpartum
Participants are randomly assigned to either use the TENS device during breastfeeding or receive standard postpartum pain care. Pain levels and medication use will be recorded during two consecutive breastfeeding sessions within the first 48 hours after delivery.
2 breastfeeding sessions
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Hanna Kahila, Terhi Saisto, Satu Kivitie-Kallio...
https://pubmed.ncbi.nlm.nih.gov/17364281/Rajan Radhakrishnan, Steven A Moore, Kathleen A Sluka
https://pubmed.ncbi.nlm.nih.gov/12927629/Benjamin I Silbert, Stephanie J P Lam, Robert D Henderson...
https://pubmed.ncbi.nlm.nih.gov/24329649/Tina B McKay, Shrestha Priyadarsini, Dimitrios Karamichos
https://pubmed.ncbi.nlm.nih.gov/31614631/Esteban Vera Pingitore, Elvira María Hebert, Fernando Sesma...
https://pubmed.ncbi.nlm.nih.gov/19370073/Abdullah Alswied, Leonard N Chen, Kamille Aisha West-Mitchell
https://pubmed.ncbi.nlm.nih.gov/39743343/Holy Family Hospital, Nazareth, Israel
Lead Sponsor